Skip to main content
Livermore
Livermore
ZHEN

Ensign Peak Advisors, Inc

SEC CIK
0001454984
Latest filing
Aug 14, 2026

RYTM holding history

Rhythm Pharmaceuticals, Inc. in every 13F filed by Ensign Peak Advisors, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RYTM overviewAll 13F holders of RYTMFull Q2 2026 holdings

Shares (Q2 2026)
3,709
Value
$411.8K
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of RYTM by Ensign Peak Advisors, Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20263,709$411.8K<0.1%−150−3.9%ReducedHolders
Q1 20263,859$335.6K<0.1%00.0%UnchangedHolders
Q4 20253,859$413.1K<0.1%−107,685−96.5%ReducedHolders
Q3 2025111,544$11.3M<0.1%+93,885+531.7%AddedHolders
Q2 202517,659$1.12M<0.1%00.0%UnchangedHolders
Q1 202517,659$935.4K<0.1%00.0%UnchangedHolders
Q4 202417,659$988.6K<0.1%00.0%UnchangedHolders
Q3 202417,659$925.2K<0.1%00.0%UnchangedHolders
Q2 202417,659$725.1K<0.1%00.0%UnchangedHolders
Q1 202417,659$765.2K<0.1%−891−4.8%ReducedHolders
Q4 202318,550$852.7K<0.1%00.0%UnchangedHolders
Q3 202318,550$425.3K<0.1%+2,350+14.5%AddedHolders
Q2 202316,200$267.1K<0.1%+16,200NewHolders
Q1 20230$00.0%−108,562−100.0%Sold outHolders
Q4 2022108,562$3.16M<0.1%+97,392+871.9%AddedHolders
Q3 202211,170$274.0K<0.1%−18,175−61.9%ReducedHolders
Q2 202229,345$122.0K<0.1%+24,255+476.5%AddedHolders
Q1 20225,090$59.0K<0.1%00.0%UnchangedHolders
Q4 20215,090$51.0K<0.1%+5,090NewHolders
Q3 20210$00.0%−40,891−100.0%Sold outHolders
Q2 202140,891$801.0K<0.1%00.0%UnchangedHolders
Q1 202140,891$870.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.